AZ13705339 hemihydrate

AZ13705339 半水合物

AZ13705339 hemihydrate

A659265-5mg

5mg

≥99%

-20°C储存

超低温冰袋运输

AZ13705339 hemihydrate is a highly potent and selective PAK1 inhibitor with IC 50 s of 0.33 nM and 59 nM for PAK1 and pPAK1, respectively. AZ13705339 hemihydrate has binding affinities to PAK1 and PAK2 , with K d s of 0.28 nM and 0.32 nM, respectively. AZ Appearance:Solid IC50& Target:PAK2 0.32 nM (Kd) PAK1 0.28 nM (Kd) PAK1 0.33 nM (IC 50 ) pPAK1 59 nM (IC 50 ) In Vitro:AZ13705339 (1 μM) hemihydrate inhibits αIgM-controlled adhesion and not PMA-induced adhesion in Namalwa cells. AZ13705339 (300 nM, 30 min) prevents Siglec-8 engagement-induced eosinophil death. MCE has not independently confirmed the accuracy of In Vivo:AZ13705339 hemihydrate (100mg/kg, P.O.) has moderate clearance and oral C max of 7.7 μM in rats. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Biological Activity:AZ13705339 hemihydrate is a highly potent and selective PAK1 inhibitor with IC 50 s of 0.33 nM and 59 nM for PAK1 and pPAK1, respectively. AZ13705339 hemihydrate has binding affinities to PAK1 and PAK2 , with K d s of 0.28 nM and 0.32 nM, respectively. AZ

C33H36FN7O3S.1/2H2O

638.77 g/mol

N#CC1=CC=CC=C1CN(C2=NC(NC3=CC=C(N4CCN(C)CC4)C(S(=O)(CC)=O)=C3)=NC=C2F)C5=CC(CO)=CC=C5C.[1/2].O

DMSO : 100 mg/mL (156.55 mM; Need ultrasonic)